Yıl: 2021 Cilt: 28 Sayı: 1 Sayfa Aralığı: 63 - 70 Metin Dili: İngilizce DOI: 10.14744/less.2021.24382 İndeks Tarihi: 30-01-2022

Prognostic value of neutrophil to lymphocyte ratio in patients with colon cancer undergoing open and laparoscopic curative resection

Öz:
Introduction: It is known that many patient-related factors such as pre-operative nutritional status, comorbid diseases and especially the systemic inflammatory response affect post-operative outcomes and survival as much as the success of curative resection and the pathological stage. In the present study, it has been aimed to determine the effect of neutrophil to lymphocyte ratio (NLR) on post-operative and long-term results in patients with colon cancer who underwent laparoscopic curative resection. Materials and Methods: Eligible 281 patient with colon adenocarcinoma underwent open and laparoscopic curative resection included in study. The patients were grouped as low and high NLR according to a cutoff NLR of 2.27 determined with receiver operating characteristic curve analysis and clinicopathological features, post-operative complications, and survival outcomes were compared. Results: It was found that patients with high NLR had more advanced disease and there was a significant relationship between post-operative morbidity and high NLR. No significant relationship was found between overall and disease-free survival and NLR. Conclusion: NLR, which can be measured by preoperative routine laboratory results, may be a simple, easily accessible prognostic biomarker in predicting the stage of the disease before surgery and identifying patients with high post-operative morbidity in patients with colon cancer. Considering that many factors affect long-term results, these data suggest that NLR, which is a marker that reflects the severity of the inflammatory response, is mostly associated with perioperative and short-term outcomes.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Haggar FA, Boushey RP. Colorectal cancer epidemiology: İncidence, mortality, survival, and risk factors. Clin Colon Rectal Surg 2009;22:191–7. [CrossRef]
  • 2. Aran V, Victorino AP, Thuler LC, Ferreira CG. Colorectal cancer: Epidemiology, disease mechanisms and interventions to reduce onset and mortality. Clin Colorectal Cancer 2016;15:195–203. [CrossRef]
  • 3. Dimofte G, Târcoveanu E, Taraşi M, Panait C, Lozneanu G, Nicolescu S, et al. Mean number of lymph nodes in colonic cancer specimen: Possible quality control index for surgical performance. Chirurgia (Bucur) 2011;106:759–64.
  • 4. Weiser MR. AJCC 8th Edition: Colorectal cancer. Ann Surg Oncol 2018;25:1454–5. [CrossRef]
  • 5. Panait L, Suresh S, Fancher TT, Singh-Braich P, Sim Y, Dudrick SJ. Do laparoscopic colectomy techniques compromise oncologic principles? Chirurgia 2011;106:475–8.
  • 6. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell 2010;140:883–99. [CrossRef]
  • 7. Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophillymphocyte ratio: Experience in patients with cancer. Crit Rev Oncol Hematol 2013;88:218–30. [CrossRef]
  • 8. Dolan RD, Laird BJ, Horgan PG, McMillan DC. The prognostic value of the systemic inflammatory response in randomised clinical trials in cancer: A systematic review. Crit Rev Oncol Hematol 2018;132:130–7. [CrossRef]
  • 9. Buettner S, Spolverato G, Kimbrough CW, Alexandrescu S, Marques HP, Lamelas J, et al. The impact of neutrophil-tolymphocyte ratio and platelet-to-lymphocyte ratio among patients with intrahepatic cholangiocarcinoma. Surgery 2018;164:411–8. [CrossRef]
  • 10. Farolfi A, Petrone M, Scarpi E, Galla V, Greco F, Casanova C, et al. Inflammatory indexes as prognostic and predictive factors in ovarian cancer treated with chemotherapy alone or together with bevacizumab. A multicenter, retrospective analysis by the Mito group (Mito 24). Target Oncol 2018;13:469–79. [CrossRef]
  • 11. Glazer ES, Rashid OM, Pimiento JM, Hodul PJ, Malafa MP. Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma. Surgery 2016;160:1288–93. [CrossRef]
  • 12. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004;240:205–13. [CrossRef]
  • 13. Chiang SF, Hung HY, Tang R, Changchien CR, Chen JS, You YT, et al. Can neutrophil-to-lymphocyte ratio predict the survival of colorectal cancer patients who have received curative surgery electively? Int J Colorectal Dis 2012;27:1347–57. [CrossRef]
  • 14. Shin R, Jeong SY, Yoo HY, Park KJ, Heo SC, Kang GH, et al. Depth of mesorectal extension has prognostic significance in patients with T3 rectal cancer. Dis Colon Rectum 2012;55:1220–8. [CrossRef]
  • 15. Roxburgh CS, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol 2010;6:149–63. [CrossRef]
  • 16. Lee YY, Choi CH, Kim HJ, Kim TJ, Lee JW, Lee JH, et al. Pretreatment neutrophil:lymphocyte ratio as a prognostic factor in cervical carcinoma. Anticancer Res 2012;32:1555– 61.
  • 17. Pichler M, Hutterer GC, Stoeckigt C, Chromecki TF, Stojakovic T, Golbeck S, et al. Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients. Br J Cancer 2013;108:901–7. [CrossRef]
  • 18. Zahorec R. Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 2001;102:5–14.
  • 19. Clark EJ, Connor S, Taylor MA, Madhavan KK, Garden OJ, Parks RW. Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinoma. HPB (Oxford) 2007;9:456–60. [CrossRef]
  • 20. Teramukai S, Kitano T, Kishida Y, Kawahara M, Kubota K, Komuta K, et al. Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan multinational trial organisation LC00-03. Eur J Cancer 2009;45:1950–8. [CrossRef]
  • 21. Suzuki S, Toyabe S, Moroda T, Tada T, Tsukahara A, Iiai T, et al. Circadian rhythm of leucocytes and lymphocytes subsets and its possible correlation with the function of the autonomic nervous system. Clin Exp Immunol 1997;110:500– 8. [CrossRef]
  • 22. Pine JK, Morris E, Hutchins GG, West NP, Jayne DG, Quirke P, et al. Systemic neutrophil-to-lymphocyte ratio in colorectal cancer: The relationship to patient survival, tumour biology and local lymphocytic response to tumour. Br J Cancer 2015;113:204–11. [CrossRef]
  • 23. Chen JH, Zhai ET, Yuan YJ, Wu KM, Xu JB, Peng JJ, et al. Systemic immune-inflammation index for predicting prognosis of colorectal cancer. World J Gastroenterol 2017;23:6261– 72. [CrossRef]
  • 24. Absenger G, Szkandera J, Stotz M, Postlmayr U, Pichler M, Ress AL, et al. Preoperative neutrophil-to-lymphocyte ratio predicts clinical outcome in patients with stage II and III colon cancer. Anticancer Res 2013;33:4591–4.
  • 25. Cedres S, Torrejon D, Martinez A, Martinez P, Navarro A, Zamora E, et al. Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer. Clin Transl Oncol 2012;14:864–9. [CrossRef]
  • 26. Malietzis G, Giacometti M, Askari A, Nachiappan S, Kennedy RH, Faiz OD, et al. A preoperative neutrophil to lymphocyte ratio of 3 predicts disease-free survival after curative elective colorectal cancer surgery. Ann Surg 2014;260:287–92. [CrossRef]
  • 27. Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005;91:181–4. [CrossRef]
  • 28. Ozdemir Y, Akin ML, Sucullu I, Balta AZ, Yucel E. Pretreatment neutrophil/lymphocyte ratio as a prognostic aid in colorectal cancer. Asian Pac J Cancer Prev 2014;15:2647–50. [CrossRef]
  • 29. Oh SY, Kim YB, Suh KW. Prognostic significance of systemic inflammatory response in stage II colorectal cancer. J Surg Res 2017;208:158–65. [CrossRef]
  • 30. Jia J, Zheng X, Chen Y, Wang L, Lin L, Ye X, et al. Stage-dependent changes of preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in colorectal cancer. Tumour Biol 2015;36:9319–25. [CrossRef]
  • 31. Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R, et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 2005;353:2654– 66. [CrossRef]
APA mercan ü, Çakabay B, durhan a, Erşen O, Gojayev A, Ünal A (2021). Prognostic value of neutrophil to lymphocyte ratio in patients with colon cancer undergoing open and laparoscopic curative resection. , 63 - 70. 10.14744/less.2021.24382
Chicago mercan ümit,Çakabay Bahri,durhan abdullah,Erşen Ogün,Gojayev Afig,Ünal Ali Ekrem Prognostic value of neutrophil to lymphocyte ratio in patients with colon cancer undergoing open and laparoscopic curative resection. (2021): 63 - 70. 10.14744/less.2021.24382
MLA mercan ümit,Çakabay Bahri,durhan abdullah,Erşen Ogün,Gojayev Afig,Ünal Ali Ekrem Prognostic value of neutrophil to lymphocyte ratio in patients with colon cancer undergoing open and laparoscopic curative resection. , 2021, ss.63 - 70. 10.14744/less.2021.24382
AMA mercan ü,Çakabay B,durhan a,Erşen O,Gojayev A,Ünal A Prognostic value of neutrophil to lymphocyte ratio in patients with colon cancer undergoing open and laparoscopic curative resection. . 2021; 63 - 70. 10.14744/less.2021.24382
Vancouver mercan ü,Çakabay B,durhan a,Erşen O,Gojayev A,Ünal A Prognostic value of neutrophil to lymphocyte ratio in patients with colon cancer undergoing open and laparoscopic curative resection. . 2021; 63 - 70. 10.14744/less.2021.24382
IEEE mercan ü,Çakabay B,durhan a,Erşen O,Gojayev A,Ünal A "Prognostic value of neutrophil to lymphocyte ratio in patients with colon cancer undergoing open and laparoscopic curative resection." , ss.63 - 70, 2021. 10.14744/less.2021.24382
ISNAD mercan, ümit vd. "Prognostic value of neutrophil to lymphocyte ratio in patients with colon cancer undergoing open and laparoscopic curative resection". (2021), 63-70. https://doi.org/10.14744/less.2021.24382
APA mercan ü, Çakabay B, durhan a, Erşen O, Gojayev A, Ünal A (2021). Prognostic value of neutrophil to lymphocyte ratio in patients with colon cancer undergoing open and laparoscopic curative resection. Laparoscopic Endoscopic Surgical Science, 28(1), 63 - 70. 10.14744/less.2021.24382
Chicago mercan ümit,Çakabay Bahri,durhan abdullah,Erşen Ogün,Gojayev Afig,Ünal Ali Ekrem Prognostic value of neutrophil to lymphocyte ratio in patients with colon cancer undergoing open and laparoscopic curative resection. Laparoscopic Endoscopic Surgical Science 28, no.1 (2021): 63 - 70. 10.14744/less.2021.24382
MLA mercan ümit,Çakabay Bahri,durhan abdullah,Erşen Ogün,Gojayev Afig,Ünal Ali Ekrem Prognostic value of neutrophil to lymphocyte ratio in patients with colon cancer undergoing open and laparoscopic curative resection. Laparoscopic Endoscopic Surgical Science, vol.28, no.1, 2021, ss.63 - 70. 10.14744/less.2021.24382
AMA mercan ü,Çakabay B,durhan a,Erşen O,Gojayev A,Ünal A Prognostic value of neutrophil to lymphocyte ratio in patients with colon cancer undergoing open and laparoscopic curative resection. Laparoscopic Endoscopic Surgical Science. 2021; 28(1): 63 - 70. 10.14744/less.2021.24382
Vancouver mercan ü,Çakabay B,durhan a,Erşen O,Gojayev A,Ünal A Prognostic value of neutrophil to lymphocyte ratio in patients with colon cancer undergoing open and laparoscopic curative resection. Laparoscopic Endoscopic Surgical Science. 2021; 28(1): 63 - 70. 10.14744/less.2021.24382
IEEE mercan ü,Çakabay B,durhan a,Erşen O,Gojayev A,Ünal A "Prognostic value of neutrophil to lymphocyte ratio in patients with colon cancer undergoing open and laparoscopic curative resection." Laparoscopic Endoscopic Surgical Science, 28, ss.63 - 70, 2021. 10.14744/less.2021.24382
ISNAD mercan, ümit vd. "Prognostic value of neutrophil to lymphocyte ratio in patients with colon cancer undergoing open and laparoscopic curative resection". Laparoscopic Endoscopic Surgical Science 28/1 (2021), 63-70. https://doi.org/10.14744/less.2021.24382